Search

Search Constraints

You searched for: Author/Creator Shields, Anthony F.

Search Results

1. A new prognostic and predictive tool for shared decision making in stage III colon cancer. (October 2020)

2. Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147. Issue 5 (9th May 2016)

3. Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance). Issue 3 (March 2016)

4. Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy. Issue 2 (11th July 2012)

5. Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients. (1st January 2020)

6. Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients. (1st January 2020)

7. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma. (4th June 2018)

8. Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma. Issue 8 (12th March 2020)

10. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Issue 36 (20th December 2021)